More articles from Plenary Session 3 and 4: Review and Viral Contamination and Case Studies

You have access
Case Study of Apparent Virus Contamination in Biopharmaceutical Product at Centocor
Linda C. Hendricks and Dominick A. Vacante

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 612-613; DOI: https://doi.org/10.5731/pdajpst.2011.00825
You have access
Identification and Remediation of a Cell Culture Virus Contamination
Nathan Jones

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 615; DOI: https://doi.org/10.5731/pdajpst.2011.00822
You have access
A Biotech Production Facility Contamination Case Study—Minute Mouse Virus
Jim Skrine

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 599-611; DOI: https://doi.org/10.5731/pdajpst.2011.00823
You have access
Adventitious Agent Risk Assessment Case Study: Evaluation of RotaTeq® for the Presence of Porcine Circovirus
C. S. Ranucci, T. Tagmyer and P. Duncan

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 589-598; DOI: https://doi.org/10.5731/pdajpst.2011.00827
You have access
Contamination by Porcine Circovirus Type 1: Findings, Investigations, and Learnings
Isabelle Piérard

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 614; DOI: https://doi.org/10.5731/pdajpst.2011.00826
You have access
Mouse Minute Virus (MMV) Contamination—A Case Study: Detection, Root Cause Determination, and Corrective Actions
Mark Moody, Washington Alves, Jose Varghese and Fazal Khan

PDA Journal of Pharmaceutical Science and Technology November 2011, 65 (6) 580-588; DOI: https://doi.org/10.5731/pdajpst.2011.00824

Main menu

User menu

Search

More articles from Plenary Session 3 and 4: Review and Viral Contamination and Case Studies

Readers

Author/Reviewer Information

Parenteral Drug Association, Inc.